SCHEMBL27966573

SCHEMBL27966573

CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OCCC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.59
▸ FABP3 P05413 1/20 0.59
▸ LPAR1 Q92633 4/20 0.55
▸ LPAR3 Q9UBY5 4/20 0.55
▸ ADRA1D P25100 1/20 0.54
▸ PTAFR P25105 1/20 0.54
▸ HTR1D P28221 1/20 0.54
▸ HTR2C P28335 1/20 0.54
▸ ADRA1B P35368 1/20 0.54
▸ DRD3 P35462 1/20 0.54
▸ TMEM97 Q5BJF2 1/20 0.54
▸ PRKD3 O94806 1/20 0.54
▸ PRKCG P05129 1/20 0.54
▸ PRKCB P05771 1/20 0.54
▸ PRKCA P17252 1/20 0.54
▸ PRKCH P24723 1/20 0.54
▸ AKT1 P31749 1/20 0.54
▸ PRKCI P41743 1/20 0.54
▸ PRKCE Q02156 1/20 0.54
▸ PRKCQ Q04759 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vb-201 SCHEMBL15942776 0.94 RECQL (0.64) RECQLFABP3LPAR1LPAR3ADRA1D
Vb-201 SCHEMBL19327154 0.94 RECQL (0.64) RECQLFABP3LPAR1LPAR3ADRA1D
SCHEMBL8746968 0.94 RECQL (0.64) RECQLFABP3LPAR1LPAR3ADRA1D
SCHEMBL15164286 0.94 RECQL (0.64) RECQLFABP3LPAR1LPAR3ADRA1D
SCHEMBL12345691 0.94 RECQL (0.64) RECQLFABP3LPAR1LPAR3ADRA1D
SCHEMBL19405591 0.91 LPAR1 (0.67) FABP3LPAR1LPAR3ADRA1DPTAFR
SCHEMBL22023008 0.91 LPAR1 (0.67) FABP3LPAR1LPAR3ADRA1DPTAFR
SCHEMBL20851913 0.91 LPAR1 (0.67) FABP3LPAR1LPAR3ADRA1DPTAFR
SCHEMBL22023007 0.91 LPAR1 (0.67) FABP3LPAR1LPAR3ADRA1DPTAFR
SCHEMBL14447803 0.91 LPAR1 (0.67) FABP3LPAR1LPAR3ADRA1DPTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103874485-A Formulations and dosage forms of oxidized phospholipids VASCULAR BIOGENICS LTD 2014-06-18 — — CN disclosed
Send feedback